Contact
searchSearch
HMP Global

Innovations in IO Interview

Dr. David Breen and Dr. Maxine Tran
Video
Partnership of Interventional Radiology and Urology in the Treatment of RCC
09/01/2023
Dr. Maxine Tran and Dr. David Breen discuss the partnership of interventional radiology and urology in the treatment of RCC. Some of the topics of specific interest are the collaboration between urologists and interventional radiologists,...
Dr. Maxine Tran and Dr. David Breen discuss the partnership of interventional radiology and urology in the treatment of RCC. Some of the topics of specific interest are the collaboration between urologists and interventional radiologists,...
Dr. Maxine Tran and Dr. David...
09/01/2023
IO Learning
Dr. Solomon Dr. Elsayed Future of IO
Interview
The Future of IO: Embracing the ‘Pioneer Spirit’ of Innovative Cancer Care
08/22/2023
Mohammad Elsayed, MD; Stephen B. Solomon, MD
The interventional oncology field is one that is ever-expanding and bringing fresh perspectives and innovative solutions for cancer care to the forefront of the health industry. IO Learning recently interviewed  Mohammad Elsayed, MD,...
The interventional oncology field is one that is ever-expanding and bringing fresh perspectives and innovative solutions for cancer care to the forefront of the health industry. IO Learning recently interviewed  Mohammad Elsayed, MD,...
The interventional oncology...
08/22/2023
IO Learning
Interview
Phase I First-in-Human Study on the Use of Embrace Liquid Embolic for the Treatment of Hypervascular Tumors
06/14/2022
Ami Peltier
IO Learning spoke with Gerard S. Goh, MBBS, co-investigator of a recent pilot study on the Embrace Hydrogel Embolic System for the treatment of benign and malignant hypervascular tumors.
IO Learning spoke with Gerard S. Goh, MBBS, co-investigator of a recent pilot study on the Embrace Hydrogel Embolic System for the treatment of benign and malignant hypervascular tumors.
IO Learning spoke with Gerard S....
06/14/2022
IO Learning
Dr Tomkovich
Podcasts
Interview With Dr Kenneth Tomkovich: ICE3 Trial 3-Year Interim Results
10/20/2021
The ICE3 trial was designed to evaluate the safety and efficacy of breast cryoablation in women older than 60 years with low-risk early-stage breast cancers. Dr Kenneth Tomkovich, co-principal investigator of ICE3, joined us to discuss the...
The ICE3 trial was designed to evaluate the safety and efficacy of breast cryoablation in women older than 60 years with low-risk early-stage breast cancers. Dr Kenneth Tomkovich, co-principal investigator of ICE3, joined us to discuss the...
The ICE3 trial was designed to...
10/20/2021
IO Learning

Browse Our Other Brands

Oncology Learning Network

 

Cardiovascular Learning Network

 

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use